Discussion of the Indonesia medical devices market often starts with scale and momentum, but the more important story is how policy and procurement shape winners. One view projects growth at an annual rate of 8% to reach US$3.2 billion by 2029, and expects Indonesia to capture about 20% of Southeast Asia’s medical device market share within that timeframe. Another forecast values the national market at USD 61.71 billion in 2024 and projects USD 111.38 billion by 2032, with a CAGR of 7.97% (2025–2032). These differing figures highlight the need to validate scope and definitions, yet both point to a market where foreign suppliers see demand, while government priorities increasingly influence routes to market.
Import dependence remains central even as protectionist measures aim to boost domestic output. In value terms, imported products accounted for just over 53% at US$1.5 billion in 2019, despite policies designed to strengthen local manufacturing. The import landscape is also visible through supplier shares and category shifts. China is described as the main importing country with a 20% market share, followed by Germany with 15%. A separate import-focused view notes Germany at $368.9 million and Japan at $171.2 million, with Japan showing +79.3% growth. The same source links demand to high-end segments, noting Radiology growth of +69.8% alongside a modernization drive that can favor advanced surgical and diagnostic equipment.
Localization Pressure Meets Import Substitution Realities
Indonesia’s policy environment creates a dual-track market: modernization needs pull in sophisticated imports, while Domestic Content Level (TKDN) policies push buyers and suppliers toward local value-add. This tension is tied to the Health System Transformation Agenda (HSTA), positioned as a national push to modernize hospitals and improve service quality, while also addressing outbound medical tourism that costs the nation $10.6 billion annually. In practice, localization pressure exists alongside gaps in local capability. Domestic manufacture is described as focusing on lower value devices such as surgical gloves, bandages, orthopedic aids, and hospital furniture. That profile helps explain why advanced equipment categories can remain import-reliant even as procurement rules and industrial policy encourage substitution.
Demand signals also show up in specific care settings and submarkets. In one market breakdown, Diagnostics is listed as the largest application segment in 2024, with revenue of USD 55.81 billion, while Homecare Settings is cited as the fastest-growing end-user segment with a CAGR of 10.87% from 2024 to 2032. For imaging specifically, Indonesia’s medical imaging market size is estimated at USD 347.4 million in 2025 and projected to reach USD 527.6 million by 2033, growing at a CAGR of 5.4% from 2026 to 2033. On-the-ground utilization examples include RSJPD Harapan Kita Hospital reporting approximately 124,000 outpatient visits annually and around 35,000 inpatient cases per year, including about 3,500 heart-surgery patients during their stay.
Market entry execution depends on getting regulatory and licensing decisions right early. Under Minister of Health Regulation No. 62 of 2017 (Permenkes 62/2017), roles are contract-defined: the manufacturer is responsible for technical documentation, the license holder manages registration, importation, and compliance with the Ministry of Health, and the distributor handles market distribution. Product licenses are not transferable, so changing distributors or license holders triggers re-registration under the new license holder. This is why some manufacturers opt for an independent license holder from the start, especially if they want to avoid distributor-held licenses and retain control. Practical readiness matters too: instructions for use (IFU) must be provided in the local language, with key content including product introduction, intended use, directions for use, and warnings and precautions; a bilingual Indonesian-English IFU is acceptable.
What is driving localization pressure in Indonesia’s medical device sector?
How import-dependent is Indonesia for medical devices?
What do foreign manufacturers need to know about licenses in Indonesia?
What translation is required for IFU during registration?
What are the key market themes in the Indonesia medical devices market right now?
